WHO includes molnupiravir in its Covid-19 treatment guidelines
This ninth update of WHO’s guideline on therapeutics includes a recommendation that casirivimab-imdevimab not be used for patients infected with the Omicron variant
This ninth update of WHO’s guideline on therapeutics includes a recommendation that casirivimab-imdevimab not be used for patients infected with the Omicron variant
Viralex is an immunomodulatory agent with broad-spectrum antiviral properties. It enhances both innate & adaptive immunity and strengthens the body's defence response to viral infections
High level of vaccine efficacy maintained over a 6-month period of surveillance
Flowflex antigen test detects Covid-19, including the Omicron variant, in just 15 minutes with 98.8% accuracy
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
100% efficacy against severe Covid-19 disease and hospitalizations
The first wave of shipments includes several countries, such as Germany, France and Austria
Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR
New biotechnology product aims to be world's fastest automatic sanitary solution
The grants are expected to be received over the next three years, commencing March 2022
Subscribe To Our Newsletter & Stay Updated